Fate Therapeutics (FATE) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $3.5 million.
- Fate Therapeutics' Accounts Payables fell 4481.02% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 4481.02%. This contributed to the annual value of $9.4 million for FY2024, which is 9845.31% up from last year.
- As of Q3 2025, Fate Therapeutics' Accounts Payables stood at $3.5 million, which was down 4481.02% from $4.0 million recorded in Q2 2025.
- Fate Therapeutics' Accounts Payables' 5-year high stood at $11.4 million during Q1 2022, with a 5-year trough of $3.5 million in Q3 2025.
- Moreover, its 5-year median value for Accounts Payables was $6.8 million (2024), whereas its average is $7.1 million.
- In the last 5 years, Fate Therapeutics' Accounts Payables plummeted by 5745.04% in 2021 and then soared by 9845.31% in 2024.
- Fate Therapeutics' Accounts Payables (Quarter) stood at $8.6 million in 2021, then decreased by 4.03% to $8.3 million in 2022, then tumbled by 42.9% to $4.7 million in 2023, then skyrocketed by 98.45% to $9.4 million in 2024, then plummeted by 62.58% to $3.5 million in 2025.
- Its Accounts Payables stands at $3.5 million for Q3 2025, versus $4.0 million for Q2 2025 and $4.2 million for Q1 2025.